This indicates that ZNF692 is quite accurate in predicting the prognosis of patients with osteosarcoma, as shown in Fig. 1I. Moreover, we have previously shown that elevated levels of ZNF692 were linked to worse prognosis in individuals with osteosarcoma [25]. This evidence concerns the gene ZNF692 and osteosarcoma.